Papers: 10.3390/cancers12061575

https://doi.org/10.3390/cancers12061575

Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer

Cited by: 7
Author(s): Joo-Seok Kim, Kyung Eui Park, Yoo-Seong Jeong, YeongMun Kim, Hayeon Park, Jihye Nam, Kyungsoo Jung, Woo Sung Son, Hun Soon Jung, Jong Hwa Lee, Seong Hoon Jeong, Nam Ah Kim, Jae Du Ha, Sung Yun Cho, Yoon‐La Choi, Suk‐Jae Chung, Jun Young Choi, Sung Kyu Hong, Young Kee Shin
Published: over 6 years ago

Software Mentions 1